PharMerica CORP Additional Paid in Capital
PharMerica CORP had Additional Paid in Capital of $419.30 million as of 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2017-11-09
- 2017-09-30: Additional Paid in Capital $419.30M.
- 2017-06-30: Additional Paid in Capital $417.70M.
- 2017-03-31: Additional Paid in Capital $416.00M.
- 2016-12-31: Additional Paid in Capital $411.10M.
| Period end | Additional Paid in Capital |
|---|---|
| 2017-09-30 | $419.30M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $417.70M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $416.00M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $411.10M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $410.40M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $408.50M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $406.50M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $404.60M 10-K · filed 2017-02-24 |
| 2015-09-30 | $402.30M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $400.10M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $397.90M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $394.10M 10-K · filed 2016-02-26 |
| 2014-09-30 | $391.90M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $389.70M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $387.40M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $380.20M 10-K · filed 2015-03-02 |
| 2013-09-30 | $368.90M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $367.00M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $365.30M 10-Q · filed 2013-05-01 |
| 2012-12-31 | $363.00M 10-K · filed 2014-02-28 |
| 2012-09-30 | $361.40M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $358.80M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $357.50M 10-Q · filed 2012-05-02 |
| 2011-12-31 | $355.90M 10-K · filed 2013-02-07 |
| 2011-09-30 | $354.40M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $353.00M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $349.70M 10-K · filed 2012-02-09 |